Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy wi
- Lancet Gastroenterol. Hepatol. Jun 18 2024, S2468-1253(24)00156-0 | https://doi.org/10.1016/S2468-1253(24)00156-0